The human cerebrospinal fluid metabolome.

[1]  David I. Ellis,et al.  Metabolic fingerprinting in disease diagnosis: biomedical applications of infrared and Raman spectroscopy. , 2006, The Analyst.

[2]  A Heerschap,et al.  Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.

[3]  Erin E. Carlson,et al.  Targeted profiling: quantitative analysis of 1H NMR metabolomics data. , 2006, Analytical chemistry.

[4]  Oliver Fiehn,et al.  Applications of metabolomics in agriculture. , 2006, Journal of agricultural and food chemistry.

[5]  Elaine Holmes,et al.  Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia , 2006, PLoS medicine.

[6]  J. Trygg,et al.  Extraction and GC/MS analysis of the human blood plasma metabolome. , 2005, Analytical chemistry.

[7]  R. Summers,et al.  Detection of isopropyl alcohol in a patient with diabetic ketoacidosis. , 2000, Journal of Emergency Medicine.

[8]  Erin E. Carlson,et al.  Enrichment tags for enhanced-resolution profiling of the polar metabolome. , 2007, Journal of the American Chemical Society.

[9]  M. Chalimoniuk,et al.  Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury , 2006, Brain Research.

[10]  D. Bergel.  Geigy Scientific Tables , 1991 .

[11]  M. Bowers.  Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures. , 1972, Neuropharmacology.

[12]  Brian D. Sykes,et al.  Urine stability for metabolomic studies: effects of preparation and storage , 2007, Metabolomics.

[13]  J. Lindon,et al.  600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. , 1993, Journal of pharmaceutical and biomedical analysis.

[14]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[15]  Erik J. Saude,et al.  Optimization of NMR analysis of biological fluids for quantitative accuracy , 2006, Metabolomics.

[16]  Elaine Holmes,et al.  Metabonomics in pharmaceutical R & D , 2007, The FEBS journal.

[17]  J. Vion-Dury,et al.  Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. , 1998, Brain research. Brain research protocols.

[18]  F. Gabreëls,et al.  Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[19]  R. Surtees,et al.  Physiology and pathophysiology of organic acids in cerebrospinal fluid , 1993, Journal of Inherited Metabolic Disease.

[20]  M. Segal.  Extracellular and cerebrospinal fluids , 1993, Journal of Inherited Metabolic Disease.

[21]  Yves Gibon,et al.  GMD@CSB.DB: the Golm Metabolome Database , 2005, Bioinform..

[22]  T. Ferraro,et al.  Triple-column ion-exchange physiological amino acid analysis with fluorescent detection: baseline characterization of human cerebrospinal fluid. , 1984, Analytical biochemistry.

[23]  J. Benito-León,et al.  Cerebrospinal fluid carnitine levels in patients with Parkinson's disease , 1997, Journal of the Neurological Sciences.

[24]  D. Schomburg,et al.  GC–MS libraries for the rapid identification of metabolites in complex biological samples , 2005, FEBS letters.

[25]  Russ Greiner,et al.  Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. , 2007, Analytical chemistry.

[26]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[27]  C. Burtis.  Tietz textbook of Clinical Chemistry , 1994 .

[28]  R. Salek,et al.  Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep , 2007, Journal of neuroscience research.

[29]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.

[30]  Maria Liguori,et al.  High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques , 1996, Journal of the Neurological Sciences.

[31]  Liang Li,et al.  Stable-isotope dimethylation labeling combined with LC-ESI MS for quantification of amine-containing metabolites in biological samples. , 2007, Analytical chemistry.